title: [Corrigendum] Promoter methylation of RASSF1A modulates the effect of the microtubule-targeting agent docetaxel in breast cancer.
abstract: Following the publication of this article, an interested reader drew to our attention that there were possible anomalies in the presentation of Fig. 5B in the above article. After having examined the figure, we recognized that several errors had indeed occurred during the process of compiling the figure. A corrected version of Fig. 5 is shown below, containing new data for Fig. 5B, after our having re-performed the western blot experiment according to the identical procedure detailed in the paper. We obtained broadly similar results to those featured originally in the article; therefore, the revision of this figure does not affect the conclusions reported in the study. We thank the reader of our article who drew this matter to our attention. [the original article was published in the International Journal of Oncology 41: 611-620, 2012; DOI: 10.3892/ijo.2012.1470].
authors.affiliation: Division of Oncology/Hematology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
authors.forename: Eun Young
authors.initials: EY
authors.lastname: Gil
authors.affiliation: Division of Oncology/Hematology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
authors.forename: Uk Hyun
authors.initials: UH
authors.lastname: Jo
authors.affiliation: Division of Oncology/Hematology, Department of Pathology, Korea University College of Medicine, Seoul, Republic of Korea.
authors.forename: Hoiseon
authors.initials: H
authors.lastname: Jeong
authors.affiliation: Division of Oncology/Hematology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
authors.forename: Young Mi
authors.initials: YM
authors.lastname: Whang
authors.affiliation: Division of Oncology/Hematology, Department of Radiology, Korea University College of Medicine, Seoul, Republic of Korea.
authors.forename: Ok Hee
authors.initials: OH
authors.lastname: Woo
authors.affiliation: Division of Oncology/Hematology, Department of Radiology, Korea University College of Medicine, Seoul, Republic of Korea.
authors.forename: Kyu Ran
authors.initials: KR
authors.lastname: Cho
authors.affiliation: Division of Oncology/Hematology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
authors.forename: Jae Hong
authors.initials: JH
authors.lastname: Seo
authors.affiliation: Division of Oncology/Hematology, Department of Pathology, Korea University College of Medicine, Seoul, Republic of Korea.
authors.forename: Aeree
authors.initials: A
authors.lastname: Kim
authors.affiliation: Division of Oncology/Hematology, Department of Surgery, Korea University College of Medicine, Seoul, Republic of Korea.
authors.forename: Eun Sook
authors.initials: ES
authors.lastname: Lee
authors.affiliation: Department of Physiology, College of Medicine, Hanyang University, Seoul, Republic of Korea.
authors.forename: Insong
authors.initials: I
authors.lastname: Koh
authors.affiliation: Division of Oncology/Hematology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
authors.forename: Yeul Hong
authors.initials: YH
authors.lastname: Kim
authors.affiliation: Division of Oncology/Hematology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
authors.forename: Kyong Hwa
authors.initials: KH
authors.lastname: Park